Sparta Biomedical Raises Funds for Knee OA Treatment

Sparta Biomedical closed a heavily oversubscribed convertible funding round. The company has developed the Ormi device to treat knee osteoarthritis. Ormi was granted Breakthrough Device Designation by FDA in 2021, and also secured initial funding within that year.

The newly-secured capital will accelerate Sparta’s preparations for the...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us